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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A170indicating carry-over. Lumping the groups together resulted in a sig-
niﬁcant drop in stiffness in the morning as well as at noon, (p<0.030)
and (p<0.035), respectively, with no time difference in between. Pain
showed identical pattern: p values morning <0.020 and noon <0.015,
no time dependency. In accordance with the drop in stiffness and pain
active treatment also resulted in an signiﬁcant improved quality of
sleep, improved mood and a better wellbeing (data not given).
Conclusions: Stiffness and to some degree pain was most pronounced
in themorning. The present Rose-hip powder seemsmore potent, when
symptoms are more pronounced. This may explain improved sleeping
quality observed during active treatment. Circadian variation should be
recognized in OA patients.
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TISSUEGENE-C (INVOSSA™) IN PATIENTS WITH OSTEOARTHRITIS: A
PHASE II TRIALS
J. Cho, T. Kim, Y. Park, B. Lee. Kolon Life Sci., GwaChun, Republic of Korea
Purpose: TissueGene-C (TG-C) is a cell mediated gene therapy that
contains non-transduced (hChonJ) and transduced (hChonJb#7) human
allogeneic chondrocytes. The hChonJb#7 cells were transduced with
TGF-b1 gene by using retroviral vector and irradiated with gamma-ray.
TG-C has been demonstrated its efﬁcacy and safety in preclinical studies
in vitro and in vivo. TG-C has been proven for its safety and efﬁcacy in
Phase I and Phase IIa clinical studies in osteoarthritis (OA) patients.
The current placebo controlled phase IIb study was conducted to
determine both safety and efﬁcacy of TG-C in patients with OA of the
knee.
Methods: Participants (n ¼ 54) with a conﬁrmed diagnosis of knee OA
by X-ray and MRI were randomized into the treatment group (TG-C,
1.8x107cells/knee, n ¼ 27) and the placebo group (saline, n ¼ 27). The
primary evaluation parameter was International Knee Documentation
Committee (IKDC) which measures pain, sports activities, and daily
function. The secondary evaluation parameters were Western-Ontario
and MacMaster University (WOMAC) score, Knee Injury and Osteo-
arthritis Outcome Score (KOOS), and 100 mm Visual Analogue Scale
(VAS). These parameters were assessed at 12 and 24 weeks post
treatment. For TG-C treatment group, the evaluation was extended to
48 weeks post treatment.
Additionally, changes in biomarkers were assessed in serum and urine
samples. Safety measures, including physical exams, complete blood
count, and serum chemistry were included up to 6 months post treat-
ment. Blood samples were screened to detect the replication competent
retrovirus (RCR), retrovirally transduced cells, and TGF-b1 DNA and
protein starting from 2 weeks up to 6 months post treatment.
Results: TG-C treatment group showed improvement in IKDC, WOMAC,
KOOS and 100 mm VAS scores compared to placebo group, which was
maintained up to the 1 year.
Conclusions: In summary, the Phase IIb study indicated that TG-C
(InvossaTM) treatment improved pain, sports activities, and quality of
daily life in patients with knee OA when compared to the placebo
control.
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ROSE-HIP INCLUDING SEEDS AND SHELLS REPORTED TO REDUCE
SYMPTOMS OF OSTEOARTHRITIS, IMPROVES QUALITY OF THE SKIN
BY MECHANISMS WHICH MAY INVOLVE COLLAGEN AND
LONGEVITY OF CELL MEMBRANES
K. Winther, L. Petcharat, K. Wongsuphasawat. Inst. for Clinical Res.,
Frederiksberg C, Denmark
Purpose: Rose-hip powder, containing seeds and shells, rich in a gal-
actolipid, GOPO, was shown to alleviate pain and stiffness in osteo-
arthritis and inhibit MMP-1, an enzyme breaking down collagen, in the
cartilage of joints and in the subcutaneous tissue of the skin, causing
wrinkles. Collagen is supported by anti-oxidants including Vitamin C.
Anti-oxidants can also improve the longevity of cell membranes. Ani-
mal studies show that natural vitamin C given as part of dried rose-hip
powder is absorbed better than artiﬁcial vitamin C. The aim of this study
was to test, if the present Rose-hip powder would have any impact on
the depth of wrinkles of the face (craw feet), if natural vitamin C as part
of rose-hip powder was absorbed better than artiﬁcial vitamin C and if
the present powder would add to the longevity of cell membranes.Methods: A number of 34 healthy volunteers, 35 - 65 years of age, were
randomly allocated to 2 month oral treatment with either the strong
anti-oxidant Astaxanthin 4 mg daily, well known for its reduction of
wrinkels (n¼17) or the present standardized rose-hip powder (Hyben-
Vital®) 3 g daily (n¼17) in a blinded manner. The depth of wrinkles was
estimated initially and after 8 weeks, using a Skin Visioscan ® VC98.
Another group of 16 healthy volunteers were given either a single dose
of 15 g of the present rose-hip powder, equivalent to 125 mg of natural
vitamin C or a single dose of 250 mg of artiﬁcial vitamin C. Blood levels
of vitamin C was estimated initially and after 1, 2, 4 and 6 hours using
photometric methodology. Eighteen other healthy volunteers were
treated with Rose-hip powder 45 g daily for 28 days. Red cells were
isolated before and after 14 and 28 days of treatment, respectively, and
again one month after stopping treatment. Each portion of blood was
stored in a blood bank for 5 weeks. Then the leak of haemoglobin (HGB)
from red cells into the surrounding medium, indicating cell membrane
disintegration, was measured. TheWilcoxon test was used for statistical
evaluation within groups. Mann-Whitney for differences between
groups. Data given is mean þ/-sd.
Results: Astaxanthin as well as Rose-hip signiﬁcantly reduced the
depth of wrinkels: Visioscan index initially: Astaxanthin 46.1 þ/- 7.8 vs
two month 42.2 þ/- 5.5 (p < 0.003). Rose-hip resulted in a similar and
signiﬁcant reduction of wrinkles: 45.9 þ/-9.9 vs 42.1 þ/- 5.4 (p<0.034).
No difference between groups (Mann-Whitney p value p<0.995).
Patients reported that theywere equally satisﬁed by the two treatments
(data not given). The lower dose of natural vitamin C (125 mg) given as
rose-hip powder resulted in an improvement from 76.85 þ/- 23.0
peaking after two hours 122.15 þ/- 14.4 mmol/l (p<0.010). A similar
pattern was seen when using the double dose of artiﬁcial vitamin C:
initial level 71.7 þ/- 25.6 peaking after 2 hours 119.1 þ/- 21.0 mmol/l
(p<0.010). No signiﬁcant difference comparing groups. The leak of HGB,
from erythrocytes, signiﬁcantly declined during Rose-hip treatment.
Initial value 57.2 þ/-13.9 vs 2 weeks treatment 49.2 þ/-16.2 (p<0.01).
One month after stopping treatment, HBG levels were back to initial
values (p<0.010).
Conclusions: The present data suggest that Rose-hip powder con-
taining seeds and shells can have some impact on the protection of
collagen and that vitamin C given in its natural form as a part of dried
rose-hip powder is better absorbed than artiﬁcial vitamine C. The
present rose-hip powder seems to improve the longevity of cell
membranesEpidemiology
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THE PREVALENCE AND DIAGNOSTIC ACCURACY OF CLINICAL EXAM
TESTS IN IDENTIFYING RADIOGRAPHIC FEMOROACETABULAR
IMPINGEMENT (FAI): A PROSPECTIVE POPULATION-BASED STUDY
C. Ratzlaff y, L. Li z, H. Wong z, J. Kopec z, C. Zhang z, J. Esdaile z,
H. Qian z, M. Barber z, B. Forster z. yBrigham and Women's Hosp. /
Harvard Med. Sch., Boston, MA, USA; zUniv. of British Columbia,
Vancouver, BC, Canada
Purpose: Femoroacetabular impingement (FAI) is common and some-
times associated with hip pain, labral and chondral pathology and
osteoarthritis. The gold standard for diagnosis for bony FAI is specialized
radiographic views and/or speciﬁc MRI sequences.
Currently, no physical examination tests can accurately conﬁrm or
discard the presence of radiographic FAI. A recent systematic review
found a critical absence of high quality studies and was unable to
provide a clinical recommendation (Tijssen et al 2012). Almost all
previous studies suffer from spectrum bias (most subjects had hip
pathology) and the majority of studies from small samples.
The objective was to undertake the largest, and ﬁrst population-based
study to estimate the prevalence and diagnostic accuracy of physical
exam tests in identifying radiographic FAI in Caucasian and Chinese
samples
Methods: A random population-based sample of 711 subjects (510
Caucasian and 201 Chinese) was recruited in Vancouver, Canada. The
sample was stratiﬁed on the presence/absence of hip pain to recruit
equal numbers of both. Individuals between 20 and 49 years were eli-
gible if they reported both parents were of Caucasian or Chinese
descent and could attend a two-hour session, consisting of physical
(continued)
Characteristic Caucasian
(N ¼ 510)
Chinese
(N ¼ 201)
FABER test positive 216/1020 (21.2%) 25/402 (6.2%)
F90/IR/add 331/994 (33.3%) 52/400 (13.0%)
ROM_IR <20 degrees 113/1020 (11.1%) 21/402 (5.2%)
Table 2a
Accuracy of diagnostic tests in a Caucasian sample (n¼1020 hips) for radiographic
FAI (at least one of 3 tests present) (prevalence of FAI: 40%)
Test Overall
agreement
Sensitivity Speciﬁcity Positive
predictive
Negative
predictive
Faber (Patrick) 0.57 0.23 0.80 0.43 0.60
IR pain 0.59 0.23 0.83 0.48 0.61
Post impingement 0.59 0.11 0.90 0.43 0.61
f120_add_ir_pain 0.50 0.55 0.47 0.40 0.63
f90_add_ir_pain 0.55 0.35 0.68 0.43 0.60
Anterior Impingement
(f90_add_c_pain)
0.57 0.21 0.81 0.41 0.61
f120_add_c_pain 0.52 0.44 0.57 0.39 0.63
ROM_IR<20 0.63 0.17 0.93 0.62 0.62
ROM_ﬂex<115 0.60 0.16 0.90 0.52 0.61
ROM_IR & FABER 0.61 0.07 0.98 0.69 0.60
ROM_IR & F90_IR 0.61 0.07 0.97 0.68 0.60
Table 2b
Accuracy of diagnostic tests in a Caucasian sample (n¼1020 hips) for radiographic
FAI (at least one of 3 tests present) plus hip pain (prevalence of FAI plus pain: 14%)
Test Overall
agreement
Sensitivity Speciﬁcity Positive
predictive
Negative
predictive
Faber (Patrick) 0.75 0.37 0.82 0.27 0.87
IR_pain 0.77 0.39 0.84 0.33 0.87
Post impingement 0.80 0.18 0.92 0.29 0.86
f120_add_ir_pain 0.53 0.74 0.50 0.20 0.92
f90_add_ir_pain 0.68 0.55 0.70 0.27 0.89
Anterior Impingement
(f90_add_c_pain)
0.75 0.33 0.83 0.26 0.86
f120_add_c_pain 0.59 0.60 0.59 0.18 0.90
ROM_IR<20 0.80 0.22 0.91 0.32 0.86
ROM_ﬂex<115 0.78 0.20 0.89 0.26 0.85
ROM_IR & FABER 0.84 0.13 0.97 0.50 0.85
ROM_IR & F90_IR 0.83 0.11 0.97 0.43 0.85
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A171exam, radiographs and a questionnaire. Pregnant women and those
with bilateral joint replacements were excluded.
An AP pelvis and bilateral Dunn radiographs were acquired. A trained
reader, blinded to exam ﬁndings, evaluated 3 radiographic signs. FAI
was deﬁned as any one of lateral centre edge angle (LCE) > 40 , alpha
angle > 55 and presence of a cross-over sign.
Patients underwent examination including the anterior impingement
test and 8 other clinical tests (Table 2) related to the detection of FAI. All
tests were found to have good reliability in a previous study (Ratzlaff et
al 2013). Both hips were examined by a PT working in MSK medicine
and blinded to radiographic status.
Analysis. Validity of the FAI PE tests was assessed by a set of measures of
accuracy, including the overall agreement, sensitivity, speciﬁcity and
predictive values (PPV, NPV) of the tests using the radiographic pres-
ence of FAI as the reference standard. Secondary analysis included the
presence of both radiographic FAI and hip pain as the reference
standard. Data was analyzed at the individual hip level using a gener-
alized estimating equation method to incorporate correlation within
one subject.
Results: Both Caucasian and Chinese samples were approximately 2/3
female (Table 1). Caucasians had substantially higher proportions of
positive clinical tests and radiographic FAI. CAM impingement (alpha
angle >55), FABER test and anterior impingement was 3x higher in
Caucasians, and IR<20 2x higher.
Accuracy data for the Caucasian sample are presented in Tables 2 and 3.
When the reference standard was radiographic FAI alone, overall
agreement was about 0.60, sensitivity ranged from 0.11-0.55, and spe-
ciﬁcity for the most common tests high (0.80 - 0.97). PPV ranged from
0.41 - 0.69 and NPV about 0.6. When the reference standard was
radiographic FAI plus hip pain, accuracy generally improved. The
highest overall agreement was for a combination of the IR<20 plus
FABER with overall agreement of 0.84, sensitivity 0.13, speciﬁcity 0.97,
PPV 0.50 and NPV 0.85. A combination of IR<20 and anterior
impingement test was similar.
Conclusions: Caucasians had a substantially higher prevalence of most
positive FAI clinical and radiographic ﬁndings than Chinese. Clinical
tests for FAI generally lack sensitivity but have moderate to high spe-
ciﬁcity and negative predictive values, particularly in the presence of
hip pain.
This is the largest diagnostic accuracy study and ﬁrst population-based
study of the diagnostic accuracy of FAI clinical tests. Other studies have
been small and suffer from spectrum bias, using subjects with hip pain
and intra-articular pathology.
Low sensitivity was not unexpected. Radiographic FAI is an osseous
ﬁnding not a diagnosis. Its presence is not a sine qua non for pain or
pathology, but increases the likelihood of both given certain types of hip
movement. Other conditions at the hip (e.g., labral tears, dynamic FAI,
soft tissue inﬂammation and injury) can produce positive tests in the
absence of bony FAI. Lastly, the radiographic criteria for FAI are evolving
and may become more stringent in the future.Table 1
Characteristic Caucasian
(N ¼ 510)
Chinese
(N ¼ 201)
*Age e year 42.6 ± 7.3 Not available
Age group e no. (%)
20-29 50(10%) 41 (20.5%)
30-39 109 (21.8%) 38(19.0%)
40-49 342 (68.3%) 121 (60.5%)
Gender e no. (%)
Male 179 (35.7%) 67 (33.5%)
Female 322 (64.3%) 133 (66.5%)
BMI 26.6± 6.05 Not available
Underweight (BMI less than 18.5) 5 (0.98%)
Healthy weight (BMIs 18.5 to 24.9) 239 (46.9%)
Overweight (BMIs 25 to 29.9) 159 (31.2%)
Obese (BMI 30 and over) 107 (21%)
Hips-based (N¼1020) Hips-based
(N¼402)
Alpha >55 199/995 (20%) 33/399 (8.3%)
LCE>40 69/995 (6.9%) 12/399 (3.0%)
cross over- ﬁgure 8 204/994 (20.5%) 96/399 (24.1%)261
PROSPECTIVE EVALUATION OF MUSCULOSKELETAL INJURY HISTORY
AS PREDICTORS FOR ANTERIOR CRUCIATE LIGAMENT INJURY RISK:
THE JUMP-ACL STUDY
D.A. Padua y, K.L. Cameron z, A.I. Beutler x, S.J. de la Motte x,
K.L. Kucera y, Y.M. Golightly y, S.W. Marshall y. yUniv. of North Carolina,
Chapel Hill, NC, USA; zKeller Army Hosp., West Point, NY, USA;
xUniformed Services Univ. of the Hlth.Sci., Bethesda, MD, USA
Purpose: Anterior cruciate ligament (ACL) injuries occur in as many as
250,000 Americans each year. Within 10 years following ACL injury, 1 in
3 individuals who sustain an ACL injury demonstrate signs of knee
osteoarthritis (OA), regardless of whether or not they underwent ACL
reconstruction. Radiographic evidence of knee OA rises to 52% in ACL /
meniscus injured patients at 12 years post-injury. Therefore, it is
important to understand incident ACL injury risk factors, given the
accelerated progression to OA in those suffering an ACL injury. Prior
history of ACL injury increases an individual’s ACL injury risk by 4-6
times to both the previously injured and healthy contralateral limb.
However, it is unknown if other, more common musculoskeletal (MSK)
injuries are also associated with an elevated risk of ACL injury. Identi-
fying the association between prior MSK injuries and incident ACL
injury may help identify those individuals with elevated risk for future
ACL injury and injury-mediated knee OA. These individuals may then be
